Both Novo Nordisk and Eli Lilly now offer manufacturer self-pay programs that dramatically reduce the GLP-1 cost without insurance
In one study , researchers found that men without diabetes who took semaglutide had a slightly higher risk of being diagnosed with erectile dysfunction (ED) than those who took a placebo
In addition to the end of the shortage, Eli Lilly announced its intent to reduce prices for Zepbound, offering single-dose vials at $499 per month, down from $699, to keep pricing competitive
These agents produce modest improvements in glycated hemoglobin (HbA1c) of approximately 0.5%0.8% and a neutral profile on weight and blood pressure [28]
provide substantial contribution to interpretation of data, critically reviewed the manuscript, contribute an important intellectual content and gave final approval of the manuscript
Ask your healthcare provider to review the denial letter received from BCBS and work with them to submit an appeal